SearchResearch
Beta
Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.

Neoadjuvant Chemotherapy +/- Bevacizumab Pharmacogenomics

Request Access

Bevacizumab added to neoadjuvant chemotherapy for breast cancer.

H. Bear, G. Tang, P. Rastogi, et al. (2012). The New England journal of medicine. Cited 460 times. https://doi.org/10.1056/NEJMoa1111097

Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial.

H. Bear, G. Tang, P. Rastogi, et al. (2015). The Lancet. Oncology. Cited 137 times. https://doi.org/10.1016/S1470-2045(15)00041-8